CLINICAL_TRIALS
trial_result
· 2016-05-04
Clinical Trial Update: Post-licensure Safety Study of IMOJEV® in Thailand [Phase 4]
Summary
Phase 4 post-licensure safety study of IMOJEV conducted in Thailand has completed and results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Japanese Encephalitis | Phase 4 | Status: COMPLETED | Results posted: 2016-05-04